Cardiometabolic disease prediction, causal analysis and drug development using high-resolution 1 H- nuclear magnetic resonance (NMR) lipid and metabolomics (The UCLEB consortium)

Project Details

StatusFinished
Effective start/end date1/01/1431/12/16